Idenix Pharmaceuticals Inc. (IDIX) was a big mover last session, as the company saw its shares jump over 18% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the volatile price range of $4.41 and $5.77 in the past one-month time frame.
This biopharmaceutical company has seen no estimate revision in the last one month and its Zacks Consensus Estimate remained static over the same time frame. The recent price action is encouraging though. So, make sure to keep a close watch on this firm in the near future.
Idenix Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the med-biomed/gene industry include Osiris Therapeutics, Inc. (OSIR), Protalix BioTherapeutics, Inc. (PLX) and Sunesis Pharmaceuticals, Inc. (SNSS). While Osiris Therapeutics and Protalix BioTherapeutics hold a Zacks Rank #1 (Strong Buy), Sunesis Pharmaceuticals carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
IDENIX PHARMACEUTICALS INC (IDIX): Free Stock Analysis Report
OSIRIS THERAPEUTICS MD (OSIR): Free Stock Analysis Report
PROTALIX BIOTHERAPEUTICS INC (PLX): Free Stock Analysis Report
SUNESIS PHARMACEUTICALS INC NEW (SNSS): Free Stock Analysis Report
Zacks Investment Research
- Finance Trading
- Personal Investing Ideas & Strategies
- Osiris Therapeutics
- Sunesis Pharmaceuticals